A detailed history of New York State Common Retirement Fund transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 10,110 shares of YMAB stock, worth $112,625. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,110
Previous 12,610 19.83%
Holding current value
$112,625
Previous $152,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$9.95 - $15.39 $24,875 - $38,475
-2,500 Reduced 19.83%
10,110 $133,000
Q2 2024

Jul 31, 2024

SELL
$11.6 - $17.25 $34 - $51
-3 Reduced 0.02%
12,610 $152,000
Q1 2024

May 07, 2024

BUY
$6.57 - $18.69 $41,877 - $119,130
6,374 Added 102.16%
12,613 $205,000
Q4 2023

Feb 01, 2024

SELL
$4.88 - $7.42 $151 - $230
-31 Reduced 0.49%
6,239 $43,000
Q3 2023

Nov 07, 2023

BUY
$4.86 - $7.23 $471 - $701
97 Added 1.57%
6,270 $34,000
Q2 2023

Aug 07, 2023

SELL
$5.68 - $10.34 $295 - $537
-52 Reduced 0.84%
6,173 $42,000
Q1 2023

May 02, 2023

SELL
$2.83 - $5.11 $52,072 - $94,024
-18,400 Reduced 74.72%
6,225 $31,000
Q4 2022

Jan 30, 2023

BUY
$3.0 - $15.17 $30 - $151
10 Added 0.04%
24,625 $120,000
Q3 2022

Nov 08, 2022

BUY
$13.96 - $19.67 $851 - $1,199
61 Added 0.25%
24,615 $355,000
Q2 2022

Aug 04, 2022

SELL
$8.22 - $15.13 $205 - $378
-25 Reduced 0.1%
24,554 $372,000
Q1 2022

May 05, 2022

SELL
$6.55 - $17.42 $1.39 Million - $3.69 Million
-211,705 Reduced 89.6%
24,579 $292,000
Q4 2021

Feb 02, 2022

SELL
$15.51 - $29.31 $1.02 Million - $1.93 Million
-65,714 Reduced 21.76%
236,284 $3.83 Million
Q3 2021

Nov 02, 2021

BUY
$27.47 - $37.31 $1.65 Million - $2.25 Million
60,228 Added 24.91%
301,998 $8.62 Million
Q2 2021

Aug 02, 2021

BUY
$25.45 - $37.64 $82,534 - $122,066
3,243 Added 1.36%
241,770 $8.17 Million
Q1 2021

May 11, 2021

BUY
$29.16 - $51.96 $1.14 Million - $2.02 Million
38,928 Added 19.5%
238,527 $7.21 Million
Q4 2020

Feb 08, 2021

BUY
$37.86 - $54.26 $1.88 Million - $2.69 Million
49,619 Added 33.08%
199,599 $9.88 Million
Q3 2020

Nov 05, 2020

BUY
$35.13 - $43.62 $815,086 - $1.01 Million
23,202 Added 18.3%
149,980 $5.76 Million
Q2 2020

Aug 07, 2020

BUY
$23.66 - $49.53 $158,522 - $331,851
6,700 Added 5.58%
126,778 $5.48 Million
Q1 2020

May 06, 2020

BUY
$14.39 - $35.8 $1.43 Million - $3.55 Million
99,278 Added 477.3%
120,078 $3.13 Million
Q2 2019

Aug 09, 2019

BUY
$19.51 - $28.31 $358,984 - $520,904
18,400 Added 766.67%
20,800 $476,000
Q1 2019

May 08, 2019

BUY
$18.21 - $26.21 $43,704 - $62,904
2,400 New
2,400 $63,000

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $487M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.